Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Impaired in vivo neovascularization capacity of endothelial progenitor cells (EPC) in patients with systemic sclerosis (SSc).

endothelin

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 19 March 2014 - 08:35 AM

Impaired in vivo neovascularization capacity of endothelial progenitor cells (EPC) in patients with systemic sclerosis (SSc).

 

EPCs contribute to vascularization by being incorporated into vessel walls and by differentiating into endothelial cells and these EPC functions are impaired in SSc patients. PubMed, Arthritis Rheum, 2013 Dec 24. (Also see: Causes of Scleroderma: Endothelin)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)